Erratum to: Postmenopausal estrogen monotherapy–associated breast cancer risk is modified by CYP17A1_-34_T>C polymorphism

By  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 295-295

Springer Publishing Company

Access to resources Recommend Favorite

XRCC2 Arg188His polymorphism is not directly associated with breast cancer risk: evidence from 37,369 subjects

By Yu Ke-Da   Chen Ao-Xiang   Qiu Li-Xin   Fan Lei   Yang Chen   Shao Zhi-Ming  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 219-225

Springer Publishing Company

Access to resources Recommend Favorite

The Common 677C>T Gene Polymorphism of Methylenetetrahydrofolate Reductase Gene is not Associated with Breast Cancer Risk

By Langsenlehner U.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 2, 2003-09 ,pp. : 169-172

Springer Publishing Company

Access to resources Recommend Favorite

An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer

By Bu Dawei   Tomlinson Gail   Lewis Cheryl   Zhang Cindy   Kildebeck Eric   Euhus David  

Breast Cancer Research and Treatment, Vol. 99, Iss. 3, 2006-10 ,pp. : 257-265

Springer Publishing Company

Access to resources Recommend Favorite

The CYP17A1 −34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers

By Kaufman Bella  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 521-527

Springer Publishing Company

Access to resources Recommend Favorite